Results and discussions
To test whether Rac1 or Cdc42 alone could activate Raf-1 in intact cells, Rac1V12 or Cdc42V12 were coexpressed with Raf-1 in COS7 cells, and Raf-1 activity measured. Both Rac1V12 and Cdc42V12 reproducibly stimulated Raf-1 activity by 4-5-fold ( Figure 1a ). In contrast, RhoAV14, an activated version of the small GTPase RhoA, did not significantly stimulate Raf-1, which is consistent with the fact that Paks are not RhoA effectors.
To determine whether activation of Raf-1 by Cdc42 or Rac1 is mediated by Pak, wild-type Pak3 (Pak3wt) was cotransfected with Raf-1 into COS7 cells. Although Pak3 alone did not significantly affect Raf-1 activation, a significant activation of Raf-1 (20-30-fold) was observed when Pak3 was cotransfected with Cdc42V12 or Rac1V12 ( Figure 1a ). This synergism in Raf-1 activation may be best explained by activation of Pak3 by the small GTPases. Pak3 and Cdc42V12 (Figure 1a ) or Rac1 (data not shown) together failed to stimulate a Raf mutant in which the Ser338 residue has been substituted by Ala (RafA338), indicating that Ser338 is critical for Pak-mediated Raf-1 activation. We reported previously [2] that Raf-CX cannot be further activated by a constitutively active Pak3 mutant, although it is still inhibited by a kinase-dead Pak3 mutant (also shown in Figures 1b and 3a) . Here, we found that Cdc42V12 alone reproducibly stimulated Raf-CX to 1.8-fold of its basal activity, and that Cdc42V12 together with Pak3wt enhanced Raf-CX activity by threefold (over 80-fold against Raf-1; Figure 1b) . Consistent with previous studies [3] , our result suggests that Cdc42V12-stimulated Pak3 is a more potent regulator than the constitutively active Pak3 mutant with respect to Raf-1 activation.
Several Raf-1 mutants that are defective in Ras binding were also examined for responsiveness to Cdc42V12-activated Pak3 (Figure 2a) . As an experimental control, wildtype Raf-1, RafA84-87 and Raf-CR3 were coexpressed with the RasV12S35 effector mutant. RasV12S35 has been shown to preferentially bind and activate Raf-1 over other Ras effector proteins [4] . Whereas wild-type Raf-1 was activated by RasV12S35, neither RafA84-87 nor Raf-CR3 were significantly stimulated by this effector-selective Ras mutant (Figure 2b ). In contrast, the kinase activities of both Ras-binding-defective Raf mutants were dramatically stimulated by coexpression with Cdc42V12 and Pak3 together (Figure 2b) .
A similar activation profile was observed with two membrane-targeted, Ras-binding-defective Raf mutants, Raf-CXA84-87 and Raf-CXA84-87/S165,168 (Figure 2a,c) . In the presence of Cdc42V12, both Raf-CX mutants showed 2-3-fold stimulation of basal activity, which increased an additional 2-3-fold by further coexpression with Pak3wt. It may be inferred from our data that the activation of Pak could potentially stimulate Raf-1 activity in the absence of Ras-GTP. Ras-independent regulation of the extracellular signal-regulated kinase (Erk) pathway has been documented in several biological processes such as [15, 16] . Raf-CR3 lacks the entire amino-terminal regulatory region containing all known determinants of Ras association. In addition to the RBD mutations, Raf-CXA84-87/S165,168 has two Cys-to-Ser substitutions in the cysteine-rich domain (CRD), which has been demonstrated to interact with regions of Ras distinct from the effector loop [15] . Each protein was expressed in COS7 cells with a Myc epitope tag, was immunoprecipitated and detected by immunoblotting with anti-Myc epitope integrin-mediated signaling [5] , mitosis [6] and signaling of some G-protein-coupled receptors [7] . Full activation of Raf-1 is the cooperative effort of multiple processes. Nevertheless, different degrees of Raf-1 activity in normal cells can result in very different outcomes [8] , demonstrating the need for stepwise control of the Raf kinases. Ras-independent activation of Raf-1 by serine/threonine or tyrosine kinases could be one way of achieving a minimal degree of activation under conditions when full activation of the Ras pathway is undesirable.
Here and in previous studies, we noticed that the measured activity of Raf-CX was reproducibly lower than that of wild-type Raf-1 stimulated by RasV12, typically onethird to one-half that of RasV12-stimulated wild-type Raf-1 [9] . Coexpression of RasV12 with Raf-CX further increased the kinase activity of Raf-CX (Figure 2d ). This phenomenon may indicate that the role of Ras in Raf activation is not limited to targeting Raf to the plasma membrane. In addition to membrane recruitment, the contribution of Ras towards Raf-1 activation may be the conformational change of a membrane-targeted Raf-1 molecule induced by Ras binding [1] . Additionally, crosstalk between another Ras effector pathway and Raf-1 might also act to modulate the level of kinase signaling following membrane localization of Raf-1. We observed that, although unable to associate with Ras, the Raf-CXA84-87 or Raf-CXA84-87/S165,168 mutants were efficiently activated by RasV12 (Figure 2d ). These results argue that oncogenic Ras can indeed activate a Raf-1 modulatory pathway, independent of any physical association between the two proteins. Moreover, the RasV12 activation of all three membrane-targeted forms of Raf-1 was inhibited by cotransfecting a kinase-dead Pak mutant (Pak3dn; Figure 2d ), indicating that Pak serves as one downstream component of Ras signaling that can promote Raf-1 activation.
Our data suggest a model in which Ras triggers a Pakdependent pathway to increase Raf-1 activity beyond that obtained strictly through a Ras-Raf interaction. As also found in the Drosophila Torso signaling pathway, Ras1 is required for the function of a truncated Draf CR3 lacking the RBD and CRD regions [10] . Therefore, the function of Ras in Raf activation is not only to interact physically with the protein kinase through the RBD/CRD, but also to activate a second component, which acts directly on the catalytic domain. Among the Ras effectors, PI 3-kinase has been reported to regulate the activation of Rho family small GTPases through Dbl family guanine-nucleotide exchange factors (GEF) [11] . The observation that Cdc42 and Rac1 readily stimulated Raf-1 activity suggested that PI 3-kinase might be the second Ras effector acting upstream to regulate the Pak-dependent Raf-1 activation [12] .
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Figure 3
Pak-mediated regulation of Raf-1 by PI 3-kinase. (a) Left, wild-type Raf-1 or RafA338 was coexpressed with RasV12C40 in the absence or presence of Pak3wt. Right, inhibition of RasV12C40-stimulated Raf-1 or Raf-CX alone by either kinase-dead Pak3 (Pak3dn) or the dominant-negative PI 3-kinase regulatory subunit, p85∆. (b) Raf-CXA84-87 was expressed alone or in combination with p110-CX, an active form of PI 3-kinase, in the absence or presence of Pak3dn, Cdc42N17, or Rac1N17. (c) COS7 cells expressing Raf-1 or Raf-CXA84-87 were treated with 100 ng/ml EGF (similar results were obtained with 10 ng/ml EGF) for 10 min after the cells were incubated with DMSO, wortmannin (Wm, 100 nM) or LY294002 (LY, 100 µM). Myc-Raf-1 kinase activity was then measured as described. Data presented are the average of the results from three assays. To address this hypothesis, we first examined a PI 3-kinase-selective Ras effector mutant, RasV12C40, for its ability to stimulate Raf-1. RasV12C40 has been shown to interact with the PI 3-kinase p110 catalytic subunit but not with Raf or RalGDS [4] . Coexpression of RasV12C40 with wild-type Raf-1 resulted in a ten-fold activation of kinase activity. This activation was Ser338 dependent and was enhanced by Pak3wt and inhibited by Pak3dn (Figure 3a ). Next, we tested the sensitivity of Raf-1 activation to p85∆, a deletion mutant of the PI 3-kinase regulatory subunit, which is defective in association with the PI 3-kinase catalytic subunit [13] and functions as a dominant inhibitor of PI 3-kinase [14] . We found that the coexpression of p85∆ with Raf-CX or RasV12C40 and Raf-1 caused a 50% reduction of Raf kinase activity (Figure 3a) . As supporting evidence, coexpression of a constitutively active PI 3-kinase, p110-CX [14] , with Raf-CXA84-87 resulted in a twofold activation of this Raf mutant. Activation by p110-CX was blocked by coexpression with Cdc42N17, Rac1N17 or Pak3dn (Figure 3b ), suggesting that PI 3-kinase upregulates Raf-1 through Cdc42/Rac1 and Pak.
We further investigated the involvement of PI 3-kinase in Raf-1 activation using two pharmacological inhibitors of PI 3-kinase, wortmannin and LY294002. In COS7 cells, a 15-fold activation of Raf-1 was obtained by stimulating the cells with EGF. This activation was significantly reduced when wortmannin or LY294002 was present during EGF stimulation (Figure 3c ), or when Pak3dn was coexpressed with Raf-1 (data not shown). The stimulation of Raf-CXA84-87 by EGF was also attenuated by wortmannin or LY294002 (Figure 3c ), demonstrating regulation of Raf-1 by PI 3-kinase independent of a Ras-Raf-1 interaction. Furthermore, we determined the extent of phosphorylation of Raf-1 on serine 338 in EGF-treated COS7 cells using a specific anti-phosphoSer338 antiserum. As shown in Figure 3d , phosphorylation of Raf-1 Ser338 was significantly induced upon EGF stimulation. Both wortmannin and LY294002 effectively inhibited EGF-induced Ser338 phosphorylation in a dose-dependent manner, suggesting that Ser338 phosphorylation is regulated by PI 3-kinase (Figure 3d ). We conclude from the above results that activated Ras does in fact increase the degree of Raf-1 kinase activation through crosstalk through a PI 3-kinase-Cdc42/Rac-Pak signaling pathway (as depicted in the Supplementary material).
The signal connection between Ras and Raf-1 thus appears to be both direct and indirect. Physical association between the two proteins results in membrane localization of Raf-1 as well as a conformational change favorable to kinase activation. Through the stimulation of a second Ras effector, PI 3-kinase, Ras activates a Cdc42/Rac-coupled signal transduction cascade which stimulates the Pak protein kinases. Pak phosphorylates Ser338 in the Raf-1 catalytic domain, resulting in potent activation of Raf-1 kinase activity. In this way, the cell can closely regulate the degree of Raf-1 kinase activity through multiple levels of control: Ras-GTP, PI 3-kinase, Cdc42-GTP/Rac-GTP and Pak.
Supplementary material
Additional results and discussion, additional methodological details and a model for the dual role of Ras in regulating the Raf-1 kinase are available at http://current-biology.com/supmat/supmatin.htm.
